
Profluent is a biotech platform that uses AI to design and author new proteins, including creating the world's first AI-designed gene editor (OpenCRISPR). The platform leverages machine learning to turn possibilities into reality, enabling the creation of proteins that can transform medicine, agriculture, and other industries. Their approach combines biological knowledge with generative AI to write new genetic sequences and functional proteins from scratch or inspired by natural scaffolds. The core technology focuses on programmable protein design, moving beyond discovery to active authorship of biological machines. This includes developing novel recombinases for genetic medicine, as highlighted by their strategic partnership with Eli Lilly. Target users include biotech researchers, pharmaceutical developers, and industrial biologists working on therapeutics, genetic editing tools, and engineered enzymes.
The complete picture — from everyday features to the technical detail builders and IT folks dig for.
Monthly Visits
—
October 2026
Growth Rate
0%
vs last month
Dominance
0%
in Search
Top Country
—
Top Countries Breakdown
—
Growth Trend
Stable
Traffic has remained stable.
Profluent uses a paid pricing structure. Real-time rates, custom enterprise quotas, and plan details are managed directly on their official platform.
Check Pricing on ProfluentData refreshed weekly. No paid placements.
Help others make informed decisions. Your honest feedback shapes the community's understanding of this tool.
Your comment is published immediately.
No comments yet
Be the first to share your experience with this tool.
Here's what else is out there.